moxifloxacin has been researched along with Vaginitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, A; Geng, N; Wang, Y; Xue, F; Yue, Y; Zhang, H | 1 |
| Amsden, GW; Martinez, FJ; Rothermel, CD; Treadway, G; Zervos, M | 1 |
2 trial(s) available for moxifloxacin and Vaginitis
| Article | Year |
|---|---|
Aerobic vaginitis and mixed infections: comparison of clinical and laboratory findings.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria, Aerobic; Candidiasis, Vulvovaginal; China; Coinfection; Diagnosis, Differential; Drug Administration Schedule; Female; Fluoroquinolones; Follow-Up Studies; Humans; Incidence; Moxifloxacin; Quinolines; Trichomonas Vaginitis; Vaginitis; Vaginosis, Bacterial | 2013 |
Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
Topics: Abdominal Pain; Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Bronchitis, Chronic; Drug Administration Schedule; Female; Fluoroquinolones; Haemophilus influenzae; Haemophilus parainfluenzae; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Moxifloxacin; Nausea; Patient Compliance; Quinolines; Single-Blind Method; Streptococcus pneumoniae; Treatment Outcome; Vaginitis | 2007 |